These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8511518)

  • 1. Boosting effect of a second dose of measles vaccine given to 12-year-old children.
    Böttiger M
    Scand J Infect Dis; 1993; 25(2):239-43. PubMed ID: 8511518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measles antibody: comparison of long-term vaccination titres, early vaccination titres and naturally acquired immunity to and booster effects on the measles virus.
    Christenson B; Böttiger M
    Vaccine; 1994 Feb; 12(2):129-33. PubMed ID: 8147093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunity to rubella before and after vaccination against measles, mumps and rubella (MMR) at 12 years of age of the first generation offered MMR vaccination in Sweden at 18 months.
    Böttiger M
    Vaccine; 1995 Dec; 13(18):1759-62. PubMed ID: 8701590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunity to measles before and after MMR booster or primary vaccination at 12 years of age in the first generation offered the 2-dose immunization programme.
    Broliden K; Levén B; Arneborn M; Böttiger M
    Scand J Infect Dis; 1998; 30(1):23-7. PubMed ID: 9670354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunity to mumps before and after MMR vaccination at 12 years of age in the first generation offered the two-dose immunization programme.
    Broliden K; Abreu ER; Arneborn M; Böttiger M
    Vaccine; 1998; 16(2-3):323-7. PubMed ID: 9607050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes of the immunological patterns against measles, mumps and rubella. A vaccination programme studied 3 to 7 years after the introduction of a two-dose schedule.
    Christenson B; Böttiger M
    Vaccine; 1991 May; 9(5):326-9. PubMed ID: 1872016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody persistence after primary measles-mumps-rubella vaccine and response to a second dose given at four to six vs. eleven to thirteen years.
    Johnson CE; Kumar ML; Whitwell JK; Staehle BO; Rome LP; Dinakar C; Hurni W; Nalin DR
    Pediatr Infect Dis J; 1996 Aug; 15(8):687-92. PubMed ID: 8858673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measles, mumps and rubella: control by vaccination.
    van Druten JA; de Boo T; Plantinga AD
    Dev Biol Stand; 1986; 65():53-63. PubMed ID: 3556777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term follow-up study of rubella antibodies in naturally immune and vaccinated young adults.
    Christenson B; Böttiger M
    Vaccine; 1994 Jan; 12(1):41-5. PubMed ID: 8303939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccine-induced measles virus antibodies after two doses of combined measles, mumps and rubella vaccine: a 12-year follow-up in two cohorts.
    Davidkin I; Valle M
    Vaccine; 1998 Dec; 16(20):2052-7. PubMed ID: 9796064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Swedish experience of two dose vaccination programme aiming at eliminating measles, mumps, and rubella.
    Böttiger M; Christenson B; Romanus V; Taranger J; Strandell A
    Br Med J (Clin Res Ed); 1987 Nov; 295(6608):1264-7. PubMed ID: 3120971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune response after primary and re-vaccination with different combined vaccines against measles, mumps, rubella.
    Tischer A; Gerike E
    Vaccine; 2000 Jan; 18(14):1382-92. PubMed ID: 10618536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination with a combined vaccine against measles, mumps and rubella aiming at elimination of the three diseases.
    Böttiger M; Christenson B; Strandell A; Romanus V
    Dev Biol Stand; 1986; 65():37-43. PubMed ID: 3556776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination against measles, mumps and rubella (MMR): a comparison between the antibody responses at the ages of 18 months and 12 years and between different methods of antibody titration.
    Christenson B; Böttiger M
    J Biol Stand; 1985 Apr; 13(2):167-72. PubMed ID: 3997899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced Antibody Response to Infant Measles Vaccination: Effects Based on Type and Timing of the First Vaccine Dose Persist After the Second Dose.
    Carazo Perez S; De Serres G; Bureau A; Skowronski DM
    Clin Infect Dis; 2017 Oct; 65(7):1094-1102. PubMed ID: 28595358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experience with preventive measles, mumps and rubella vaccination in unified Germany].
    Gerike E; Tischer A
    Gesundheitswesen; 1993 Jan; 55(1):38-9. PubMed ID: 8435543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity and efficacy of one dose measles-mumps-rubella (MMR) vaccine at twelve months of age as compared to monovalent measles vaccination at nine months followed by MMR revaccination at fifteen months of age.
    Ceyhan M; Kanra G; Erdem G; Kanra B
    Vaccine; 2001 Aug; 19(31):4473-8. PubMed ID: 11483273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunity to measles, mumps and rubella in children vaccinated with triple viral vaccine].
    Pisón Garcés FJ; Galbe Sánchez-Ventura J; Arcauz Eguren P; Aguirre y Dabán C; Mengual Gil J; Larrad Mur L
    Aten Primaria; 1995 Mar; 15(4):235-7. PubMed ID: 7703334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody persistence in children aged 6-7years one year following booster immunization with two MMR vaccines applied by aerosol or by injection.
    Díaz Ortega JL; Castaneda D; Arellano Quintanilla DM; Martínez D; Trumbo SP; Fernández de Castro J
    Vaccine; 2017 May; 35(23):3116-3122. PubMed ID: 28457672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Measles, mumps and rubella: vaccination rate and seroprevalence in 8th grade students of 8 different sites in Switzerland 1995/96].
    Stohrer-Draxl P; Amstad H; Grize L; Gassner M; Takken-Sahli K; Bourquin C; Braun-Fahrländer C
    Praxis (Bern 1994); 1999 Jun; 88(24):1069-77. PubMed ID: 10420798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.